- Home
- BMY
as 10-29-2025 9:32am EST
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Upcoming Earnings Alert:
Get ready for potential market movements as Bristol-Myers Squibb Company BMY prepares to release earnings report on 30 Oct 2025.
| Founded: | 1887 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | 94.0B | IPO Year: | N/A |
| Target Price: | $57.54 | AVG Volume (30 days): | 16.5M |
| Analyst Decision: | Hold | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $42.75 - $63.33 | Next Earning Date: | 10-30-2025 |
| Revenue: | $47,704,000,000 | Revenue Growth: | 2.57% |
| Revenue Growth (this year): | -1.03% | Revenue Growth (next year): | -8.19% |
Latest Bristol-Myers Squibb Company News
BMY Breaking Stock News: Dive into BMY Ticker-Specific Updates for Smart Investing
24/7 Wall St.
a day ago
5 High-Yield Stocks to Anchor Your Portfolio for Half a Decade
24/7 Wall St.
a day ago
Uh Oh !! Cathie Wood Predicts “Reality Check” (Sell-off) – 5 High-Yield Dividend Safety Stocks
GlobeNewswire
a day ago
Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer
Simply Wall St.
a day ago
A Fresh Look at Bristol-Myers Squibb's Valuation After New Pipeline Progress and Phase 3 Sotyktu Results
PR Newswire
2 days ago
Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and Clinical Developments | DelveInsight
Motley Fool
2 days ago
3 Dividend-Paying Drug Stocks to Buy at a Discount
Zacks
2 days ago
What's in Store for These 5 Pharma Bigwigs This Earnings Season?
MT Newswires
2 days ago
Bristol-Myers Squibb Says New Data Show Efficacy of Sotyktu in Psoriatic Arthritis, Lupus
Compare BMY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BMY Bristol-Myers Squibb Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.